Edibeck Therapeutics
Latest round
- Series A
Last raised
- Dec 2025
Total raised
- Undisclosed
Investors
- 2
About Edibeck Therapeutics
, doing business as Edibeck Therapeutics, is a drug discovery company that focuses on CRISPR gene-editing technology. The company holds multiple patents on CRISPR gene-editing. Its founder and CEO, Mr. Zhenhuang Yang, graduated from University of Lübeck/UKSH, Germany and is an associate researcher at Nanjing Gulou Hospital. Edibeck Therapeutics is committed to the development of gene-based therapies, focusing on the research and application of foundational gene editing technologies, particularly in Type I CRISPR technology which has been applied to virus removal. The company generates revenue from developing drugs and therapies based on gene-editing technology.
Who invested in Edibeck Therapeutics
2 investors across 2 rounds
See all investors in Edibeck Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Edibeck Therapeutics
Who invested in Edibeck Therapeutics?
Edibeck Therapeutics has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Edibeck Therapeutics raised?
Edibeck Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Edibeck Therapeutics last raise money?
Edibeck Therapeutics's most recent round on record is a Series A, in Dec 2025.
What does Edibeck Therapeutics do?
, doing business as Edibeck Therapeutics, is a drug discovery company that focuses on CRISPR gene-editing technology.
Where is Edibeck Therapeutics headquartered?
Edibeck Therapeutics is headquartered in Shenzhen, China.
Which VCs invest in companies like Edibeck Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Edibeck Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Edibeck Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.